Skip to content

Actively working on recovery: The influence of physical activity on PTSD treatment outcome.

Actively working on recovery: The influence of physical activity on PTSD treatment outcome. - The influence of physical activity on PTSD treatment outcome.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49822
Enrollment
120
Registered
2020-05-15
Start date
2020-12-07
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'Post-traumatic stress disorder' and 'Stress disorder'

Interventions

Participants in both conditions will receive the same intensive TFT lasting 8 days within 2 consecutive weeks, in which daily TFT-sessions, PE and EMDR therapy, and psycho-education are combined. Th

Sponsors

PSYTREC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, subjects must meet all of the following criteria: (1) a diagnosis of PTSD based on the Clinician-Administered PTSD Scale (CAPS-5), (2) being at least 18 years old (3) sufficient knowledge of the Dutch language to undergo treatment.

Exclusion criteria

Exclusion criteria: Potential subjects who meet any of the following criteria will be excluded from participation in this study: (1) a suicide attempt less than three months prior to treatment, (2) being medically unfit to participate in the physical activity intervention operationalized as not being able to walk for at least 30 minutes (e.g., physical impairments that necessitate the use of wheelchair).

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the change in PTSD symptoms from pre- to posttreatment and at 6-month follow-up, measured with the Clinician-Administered PTSD Scale (CAPS-5) and the PTSD Checklist for DSM-5 (PCL-5).

Secondary

MeasureTime frame
The secondary outcome measures are the underlying biological and psychological mediators, measured with the Cortisol Awakening Response (CAR), inflammation levels, DNA methylation, Insomnia Severity Index (ISI), Depressive Symptomatology Self-Report (QIDS-SR), Difficulties in Emotion Regulation Scale (DERS), Dissociative Experiences Scale-II (DES-II), and the Anxiety Sensitivity Index (ASI).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)